1. Market Research
  2. > Healthcare Market Trends
LAMEA Smart Inhalers Market Size, Share & Industry Trends Analysis Report By Product, By Disease Indication, By Distribution Channel, By Country and Growth Forecast, 2021 - 2027

LAMEA Smart Inhalers Market Size, Share & Industry Trends Analysis Report By Product, By Disease Indication, By Distribution Channel, By Country and Growth Forecast, 2021 - 2027

  • March 2022
  • 90 pages
  • ID: 6273462
  • Format: PDF
  • KBV Research

Summary

Table of Contents

The Latin America, Middle East and Africa Smart Inhalers Market would witness market growth of 30.5% CAGR during the forecast period (2021-2027).

Smart inhalers, based on the time of the last dose, notify patients of missed or repeated doses and remind them to take their doses on time, simply and automatically. These reminders can be sent to the patient wherever he or she is. These gadgets can help ease the stress of remembering to take prescriptions on time, especially if there are a lot of medications to remember. They can aid in the improvement of breathing techniques and efficacy. Finally, they keep track of symptoms for both patients and doctors to see how, where, and when symptoms worsen, as well as monitor the usage of the rescue inhaler for quick relief.

The crucial issue here is that a patient’s poor control be recognized, as evidenced by the requirement of rescue or reliever medication more than twice a year. This highlights the need to scale up the preventive plan for such a person, such as retraining the patient to correctly use the inhaler or looking for trigger factors such as a new pet, tobacco smoke exposure, or airborne pollution. Smart inhalers can help expand the reach of specialist health care to remote or underserved areas, albeit adherence is generally poor. At all levels, such initiatives are also cost-effective.

There is inter-and intra-regional variation in asthma prevalence in the Middle East. The prevalence was reported to be 23.6 percent in Saudi Arabia, 19.8 percent in Qatar, and 7.8 percent to 17.3 percent in different parts of Oman. Using the ISAAC questionnaire, research from the UAE’s Al in region found a prevalence of 13 percent, while another using the ECRHS questionnaire found a range of 8 to 10% across the UAE. Asthma has a detrimental effect on people’s quality of life and contributes to the financial burden on individuals and the healthcare system. The cost of asthma medicine isn’t the only factor to consider. Outpatient consultations, inpatient stays for illness control and missed work or school are all examples of hospital visits that incur additional costs. According to the AIRGNE data, asthma causes sickness absenteeism in 30 percent of adults and 52 percent of children each year. The adoption of smart inhalers in the region can empower

The Brazil market dominated the LAMEA Smart Inhalers Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $7,116.9 Thousands by 2027. The Argentina market is anticipated to grow at a CAGR of 31.2% during (2021 - 2027). Additionally, The UAE market would display a CAGR of 30.1% during (2021 - 2027).

Based on Product, the market is segmented into Metered Dose Inhalers (MDI’s), and Dry Powdered Inhalers (DPIs). Based on Disease Indication, the market is segmented into Asthma, and Chronic Obstructive Pulmonary Disease (COPD). Based on Distribution Channel, the market is segmented into Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Adherium Limited, Aptar Group Inc. (Cohero Health Inc.), AstraZeneca, Inc., Cognita Labs, LLC, GlaxoSmithKline Plc, Novartis AG, OPKO Health, Inc., Philip Morris International, Inc. (Vectura Group Plc), Resmed, Inc. (Propeller Health), and Teva Pharmaceutical Industries Ltd.

Scope of the Study

Market Segments covered in the Report:

By Product

• Metered Dose Inhalers (MDI’s)

• Dry Powdered Inhalers (DPIs)

By Disease Indication

• Asthma

• Chronic Obstructive Pulmonary Disease (COPD)

By Distribution Channel

• Hospitals Pharmacies

• Retail Pharmacies

• Online Pharmacies

By Country

• Brazil

• Argentina

• UAE

• Saudi Arabia

• South Africa

• Nigeria

• Rest of LAMEA

Companies Profiled

• Adherium Limited

• Aptar Group Inc. (Cohero Health Inc.)

• AstraZeneca, Inc.

• Cognita Labs, LLC

• GlaxoSmithKline Plc

• Novartis AG

• OPKO Health, Inc.

• Philip Morris International, Inc. (Vectura Group Plc)

• Resmed, Inc. (Propeller Health)

• Teva Pharmaceutical Industries Ltd.

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Therapy Markets in China

  • $ 4000
  • June 2022
  • 249 pages

China’s demand for Therapy has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which ...

  • China
  • Healthcare
  • Pharmaceutical
  • Industry analysis
  • Industrial Production
  • Labour Force

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on